Dare Bioscience reported a quarterly loss of $0.02 per share, beating the Zacks consensus loss of $0.24 by $0.22. The result marks a $0.62 per-share improvement from last year's $0.64 loss, signaling meaningful year-over-year progress despite still being a loss.
Dare Bioscience reported a quarterly loss of $0.02 per share, beating the Zacks consensus loss of $0.24 by $0.22. The result marks a $0.62 per-share improvement from last year's $0.64 loss, signaling meaningful year-over-year progress despite still being a loss.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
